Centre Leon Berard

This study tested a combination of two drugs, atezolizumab and bevacizumab, in 33 adults with advanced head and neck cancer that had already been treated with chemotherapy. The goal was to see if the combination could shrink tumors or stop the cancer from growing. The study was c…

This early-phase study tested a new type of radiation therapy that targets a protein called PSMA on kidney cancer cells. Six adults with advanced clear cell kidney cancer that had spread and stopped responding to other treatments received four injections of the radioactive drug. …

This study tested a combination of two drugs (atezolizumab and cobimetinib) in children and adults with advanced soft tissue sarcoma that had spread. The goal was to see if the combo could shrink or stabilize tumors. About 229 people were enrolled, and the main focus was on how m…

This study tested whether a 6-month program using an activity tracker and weekly quizzes could improve quality of life and reduce fatigue in women with metastatic breast cancer. 124 women starting chemotherapy were randomly assigned to either receive the activity program plus rec…

This study analyzed tumor and blood samples from 84 patients with brain cancer, meningioma, or sarcoma to find biomarkers that predict how well proton beam therapy works. The goal is to identify genetic or immune markers linked to tumor shrinkage six months after treatment. This …

This study looked back at medical records of 207 adults who died from sarcoma to understand how they were cared for by palliative teams. Researchers tracked things like hospital stays in a palliative care unit, visits with a palliative doctor, and whether chemotherapy was given i…